Cite
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics
MLA
Tuija Tapaninen, et al. “Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.” Clinical Pharmacology & Therapeutics, vol. 104, Nov. 2017, pp. 158–68. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....125dd5bfbdd531cd4bf3296265640683&authtype=sso&custid=ns315887.
APA
Tuija Tapaninen, Jussi Pihlajamäki, Ville Männistö, Maria Paile-Hyvärinen, Mikko Niemi, Päivi Hirvensalo, Janne T. Backman, Vesa Kärjä, Aleksi Tornio, & Mikko Neuvonen. (2017). Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics. Clinical Pharmacology & Therapeutics, 104, 158–168.
Chicago
Tuija Tapaninen, Jussi Pihlajamäki, Ville Männistö, Maria Paile-Hyvärinen, Mikko Niemi, Päivi Hirvensalo, Janne T. Backman, Vesa Kärjä, Aleksi Tornio, and Mikko Neuvonen. 2017. “Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.” Clinical Pharmacology & Therapeutics 104 (November): 158–68. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....125dd5bfbdd531cd4bf3296265640683&authtype=sso&custid=ns315887.